Care and treatment for stomach cancer at UCLA is provided through the Gastrointestinal Oncology (GI) Program, which is facilitated by the Division of Gastrointestinal Oncology.
The Gastrointestinal Oncology Program
The GI Program at UCLA is the largest program of its kind in the Western United States and provides comprehensive cancer care to patients with a wide variety of malignant conditions of the gastrointestinal tract. Treatment is provided for cancers of the colon, rectum, anus, stomach (gastric), esophagus, pancreas, gallbladder and bile duct (cholangiocarcinoma), as well as carcinoid tumor, GIST (gastrointestinal stromal tumor) and cancers of unknown origin.
The Program offers multi-specialty coordination with experts in the fields of surgery, medical oncology, radiation oncology, radiology, nursing and social work.
Patients who come to UCLA for stomach cancer care benefit from the most advanced forms of therapy available and have access to the latest clinical trials through our clinical research unit.
Clinical trials are carefully controlled research studies in which cancer patients help doctors and scientists find ways to improve health and cancer care, and to make sure the treatments are safe and effective. Each study is designed to address and answer specific scientific questions and to find better ways to prevent, diagnose or treat cancer. A clinical trial is one of the final stages resulting from the research conducted during intensive and lengthy laboratory studies.
If you are interested in finding out more about these studies, click for more information on currently open clinical trials.
For more information on stomach cancer care at UCLA, visit the following website:
The Gastrointestinal Oncology Program at UCLA Health Systems
Department of Hematology/Oncology at UCLA